Evidence map›Paper›PMID 37284860›Full record

ArticleMedical molecular morphology2023

Intraductal papilloma with atypical ductal hyperplasia and neuroendocrine differentiation as a possible precursor lesion of solid papillary carcinoma.

Yutaro Mihara, Rin Yamaguchi, Ryuji Takahashi, Yuta Yano, Hirohisa Yano

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Medical molecular morphology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yutaro MiharaDepartment of Pathology, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, 830-0011, Japan. mihara_yuutarou@kurume-u.ac.jp.ORCID http://orcid.org/0000-0002-4119-1486
Rin YamaguchiDepartment of Pathology and Laboratory Medicine, Kurume University Medical Center, Kurume, Japan.
Ryuji TakahashiDepartment of Surgery, Social Insurance Tagawa Hospital, Tagawa, Japan.
Yuta YanoDepartment of Pathology, Social Insurance Tagawa Hospital, Tagawa, Japan.
Hirohisa YanoDepartment of Pathology, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, 830-0011, Japan.
Kurume University · JPKurume University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast papillary neoplasms include a wide range of tumor types, and their pathological diagnosis is sometimes difficult. Furthermore, the etiology of these lesions is still not fully understood. We report the case of a 72-years-old woman referred to our hospital with bloody discharge from the right nipple. An imaging study detected a cystic lesion, including a solid component contiguous with the mammary duct, in the subareolar region. The lesion was then removed by segmental mastectomy. Pathological examination of the resected specimen revealed an intraductal papilloma with atypical ductal hyperplasia. Moreover, the atypical ductal epithelial cells expressed neuroendocrine markers. The presence of an intraductal papillary lesion with neuroendocrine differentiation suggests solid papillary carcinoma. Thus, this case suggests that intraductal papilloma could be a precursor of solid papillary carcinoma.

Indexed as

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingCarcinoma, PapillaryPapilloma, IntraductalAgedCell DifferentiationFemaleHumansHyperplasiaMastectomyAtypical ductal hyperplasiaBreast cancerIntraductal papillomaNeuroendocrine differentiationSolid papillary carcinoma

Identifiers

PMID37284860
OpenAlexW4379600820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.